Breast Cancer Clinical Trial
Official title:
Self Hypnotic Relaxation As An Adjunct To Local Anesthesia During Large Core Breast Biopsy
Percutaneous large core image-guided breast biopsy is a well established tool in diagnosing breast cancer, but the associated anxiety and pain can tax the coping mechanism of even well functioning individuals. Unabated stress during an invasive procedure not only interferes with smooth progression of the ongoing procedure, but can also have deleterious effects when patients need additional procedures and dread recurrent medical traumatization. The long-term objective of this research is to provide patients with a simple coping strategy at the vulnerable time of large core biopsy in the hope that this behavioral intervention will carry over to recovery and future medical procedures. In the largest prospective randomized study of its kind, the researchers showed that a self-hypnotic intervention during percutaneous, image-guided vascular and renal interventions resulted in less pain and anxiety, greater hemodynamic stability, and fewer procedure interruptions. The positive effects of the short initial hypnotic intervention, which was structured in the procedure room, became more pronounced the longer the procedure lasted and carried over into the immediate post-procedure recovery. The investigators therefore challenge the current paradigms that long-lasting effects require intensive presurgical preparation.
Large core image-guided breast biopsy is a well established tool for diagnosing breast
cancer. Using ultrasound or X-ray guidance, a large hollow needle is inserted through the
skin into the breast and abnormal tissue is removed for diagnosis. Although this procedure
is much less invasive than open surgery, it can induce pain and anxiety that can tax the
coping mechanism of even the highest functioning individuals. Unrelieved stress during a
medical procedure not only interferes with smooth progression of the ongoing procedure, but
can also have deleterious effects when patients need additional procedures and feel dread in
anticipation. The long-term objective of this research is to provide patients with a simple
coping strategy at the time of large core biopsy, when they need it most. The hope is that
this newly learned ability to handle distress will carry over to recovery and to future
medical procedures. In a prior clinical trial (Lancet 2000:335:1486-1489), the largest
prospective randomized study of its kind, the researchers showed that a self-hypnotic
intervention during image-guided interventions of the blood vessels and the kidneys resulted
in less pain and anxiety, fewer worrisome increases and decreases of blood pressure and
heart rate, and fewer procedure interruptions. The positive effects of the short initial
hypnotic intervention, which was structured in the procedure room, became more pronounced
the longer the procedure lasted and carried over into the immediate post-procedure recovery.
Based on these past findings, the researchers therefore predict to show evidence contrary to
the current thinking that long-lasting effects require intensive presurgical preparation.
The researchers propose to pursue three interrelated specific aims:
- (Aim 1): Determine the acute effects of self-hypnotic relaxation on pain and anxiety.
Strictly defined methods of self-hypnotic relaxation (Group I), will be tested against
empathic attention (Group II) and the routine standard of care (Group III) in a
prospective randomized study with 240 patients undergoing large core breast biopsy. The
impact of the treatment will be validated by comparing during the procedure among
groups subjective measures of pain and anxiety as well as objective physiologic
indicators of pain and anxiety (frequency of significant increases in heart rate and
blood pressure).
- (Aim 2): Determine the delayed effects of self-hypnotic relaxation. Patients' levels of
pain, anxiety, and stress will be recorded through days 1-5 after the biopsy and
compared among groups. Stress levels measurements will be based on an objective test
(the amount of the stress hormone cortisol in the patient's saliva).
- (Aim 3): Determine the effect of the initial self-hypnotic relaxation on distress with
upcoming subsequent surgery in women with proven breast cancer. When patients have to
return for surgery because their biopsy revealed malignant cells, they will be given
questionnaires assessing their degree of perceived stress , anxiety, and preoccupation
with their upcoming surgery. Comparison among groups will show the durability of the
initial hypnotic intervention.
The researchers hypothesize that:
- Self-hypnotic relaxation reduces pain and anxiety during large core breast biopsy
- Self-hypnotic relaxation at the time of biopsy reduces post-biopsy stress
- Teaching patients coping skills at the critical time of the breast biopsy reduces the
patients' distress with upcoming breast surgery.
Upon completion, a short periprocedural self-hypnotic intervention will be validated by
rigorous and practical assessment in 240 patients. The relative performance of self-hypnotic
relaxation will be known compared to standard care and empathic controls in a
well-characterized population of patients with a standardized biopsy wound. The durability
of an intervention given at the earliest possible moment of breast cancer diagnosis will be
established. This opens the way to future study designs addressing long-term effects on
health behavior and psycho-physiologic phenomena.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 |